1. Sex-Specific Outcomes After Anterior Cruciate Ligament Reconstruction Using an All-Soft Tissue Quadriceps Tendon Autograft in a Young Active Population.
- Author
-
Petit CB, Slone HS, Diekfuss JA, Barber Foss KD, Warren SM, Montalvo AM, Lamplot JD, Myer GD, and Xerogeanes JW
- Subjects
- Humans, Male, Female, Adolescent, Young Adult, Sex Factors, Transplantation, Autologous, Retrospective Studies, Anterior Cruciate Ligament Reconstruction methods, Anterior Cruciate Ligament Injuries surgery, Return to Sport, Quadriceps Muscle transplantation, Autografts, Reinjuries, Tendons transplantation
- Abstract
Background: The ideal graft for anterior cruciate ligament (ACL) reconstruction (ACLR) in young athletes has a high return-to-sport (RTS) rate and a low reinjury rate. Quadriceps tendon autografts are being used with increasing frequency for ACLR in this population, despite a paucity of evidence to support their use., Purpose: To report the RTS rate, ipsilateral reinjury rate, and contralateral ACL injury rate in a young athletic population undergoing primary ACLR using an all-soft tissue quadriceps tendon (ASTQT) autograft., Study Design: Cases series; Level of evidence, 4., Methods: Patients aged 14 to 22 years who underwent primary ACLR using an ASTQT autograft by a single surgeon between January 1, 2005, and April 30, 2020, were identified via electronic medical records and contacted ≥24 months after ACLR to complete a survey regarding subsequent ipsilateral or contralateral ACL injuries and RTS. Patients who had undergone previous ACLR (ipsilateral or contralateral) were excluded., Results: A total of 656 patients (330 male, 326 female; mean age, 17.9 years) were identified, and 395 patients completed the survey (60.2%; 174 male, 221 female; mean age, 17.8 years) with a mean follow-up of 73 ± 29 months (range, 24-139 months). The RTS rate was high (male: 87.7%; female: 82.8%; P = .19). Male and female patients had similar rates of revision ACLR (male: 12.6%; female: 10.0%; P = .40) and contralateral ACL injuries (male: 13.8%; female: 11.3%; P = .46)., Conclusion: A high RTS rate and similar rates of ipsilateral and contralateral ACL injuries were found for male and female patients in a young athletic population undergoing primary ACLR using an ASTQT autograft. These results help one to better understand the utility of ASTQT grafts to support successful ACLR in young athletic populations, for which ASTQT grafts appear to yield favorable outcomes., Competing Interests: One or more of the authors has declared the following potential conflict of interest or source of funding: H.S. has received support for education from Peerless Surgical and Evolution Surgical and travel expenses from Arthrex. J.D.L. has received hospitality payments from Arthrex and Smith and Nephew; consulting fees from DePuy Synthes; and education payments from United Orthopedics, Smith and Nephew, and Elite Orthopedics. G.D.M. consults with commercial entities to support applications to the United States Food and Drug Administration but has no financial interest in the commercialization of the products; his institution receives current and ongoing grant funding from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (grants U01AR067997, R01AR070474, R01AR055563, R01AR076153, R01AR077248) and has received industry-sponsored research funding related to brain injury prevention and assessments from Q30 Innovations and ElMindA; receives author royalties from Human Kinetics and Wolters Kluwer; and is an inventor of biofeedback technologies (patent No. US11350854B2; Augmented and Virtual Reality for Sport Performance and Injury Prevention Application [approved June 7, 2022]) designed to enhance rehabilitation and prevent injuries and receives royalties or licensing fees. J.W.X. has received consulting fees from Arthrex and Trice Medical, has received compensation for services other than consulting from Arthrex, has received royalties or licensing fees from Arthrex, has received support for education from United Orthopedics, and holds stock or stock options in my-eye. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
- Published
- 2024
- Full Text
- View/download PDF